Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Belliveau

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JAMA Oncology|February 5, 2026
Prostate-Specific Membrane Antigen PET-Guided Salvage Radiotherapy-Precision or Prematurity?-ReplyColin Belliveau, Fred Saad, Cynthia Ménard
Practical Radiation Oncology|January 17, 2025
F<sup>18</sup>-DCFPyL PSMA-PET/CT Versus MRI: Identifying the Prostate Cancer Region Most at Risk of Radiation Therapy Recurrence for Tumor Dose EscalationColin Belliveau, Mustafa-Karim Benhacene-Boudam, Daniel Juneau, et al.
Trials|April 24, 2026
Platform for the Evaluation of innovations in Radiation oncology through registry-based conduct of multi-centric pragmatic randomized trials: PERa implementationPhilippe Giguère, Houda Bahig, Sydney Westra, et al.
JAMA Oncology|October 2, 2025
Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical TrialColin Belliveau, Fred Saad, Danny Duplan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JAMA Oncology|February 5, 2026
Prostate-Specific Membrane Antigen PET-Guided Salvage Radiotherapy-Precision or Prematurity?-ReplyColin Belliveau, Fred Saad, Cynthia Ménard
Practical Radiation Oncology|January 17, 2025
F<sup>18</sup>-DCFPyL PSMA-PET/CT Versus MRI: Identifying the Prostate Cancer Region Most at Risk of Radiation Therapy Recurrence for Tumor Dose EscalationColin Belliveau, Mustafa-Karim Benhacene-Boudam, Daniel Juneau, et al.
Trials|April 24, 2026
Platform for the Evaluation of innovations in Radiation oncology through registry-based conduct of multi-centric pragmatic randomized trials: PERa implementationPhilippe Giguère, Houda Bahig, Sydney Westra, et al.
JAMA Oncology|October 2, 2025
Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy: A Phase 2 Randomized Clinical TrialColin Belliveau, Fred Saad, Danny Duplan, et al.
Pageof 1